Episode 233: Dr. David Boulware

Thank you for joining us for another episode of the Low Carb MD
Podcast. Dr. David Boulware is an infectious disease
physician-scientist with formal training in clinical trials,
public health, and tropical medicine. Dr. Boulware combines his
clinical research with nested basic science investigations into
disease pathogenesis to conduct translational research. His
primary research interests are in meningitis in resource-limited
areas including diagnosis, prevention, treatment, and quality
improvement initiatives incorporating cost-effectiveness analyses
in order to translate knowledge into improved care. Dr.
Boulware’s current research is focused on improving the clinical
outcomes of HIV-infected persons with cryptococcal meningitis,
the second most common AIDS-defining opportunistic infection in
Sub-Saharan Africa and the most common cause of adult meningitis.
Dr. Boulware leads a multidisciplinary, international research
team with active research collaborations with partners in Uganda,
South Africa, Ethiopia, Brazil, Botswana, the Netherlands, and
the United Kingdom.


In their conversation, Drs. Tro and David talk about how Dr.
Boulware found his way into infectious disease, Dr. Boulware’s
career following the advent of Covid, Hydroxychloroquine studies,
Ivermectin studies, the Activ-6 trial, monoclonal antibody
treatment, Emergency Use Authorization from the FDA, and Dr.
Boulware’s take on the medical field post-Covid.


For more information, please see the links below. Thank you for
listening!


Links:


Dr. David Boulware:


Twitter



Dr. Brian Lenzkes:


Website

Twitter



Dr. Tro Kalayjian:


Website

Twitter

Instagram